Industry › MedTech
Press Releases
China Medical System Completes Dosing of the First Subject in Phase III Bridging Trial of Ruxolitinib Cream in Atopic Dermatitis in China
China Medical System Holdings Ltd.
Jun 25, 2024 20:00 HKT/SGT
Fujitsu Japan and Kamoenai Village in Hokkaido raise awareness for oral and dental healthcare
Fujitsu Ltd
Jun 19, 2024 13:20 HKT/SGT
China Medical System: Innovative Drug Methylthioninium Chloride Enteric-coated Sustained-release Tablets Approved for Marketing in China
China Medical System Holdings Ltd.
Jun 18, 2024 19:53 JST
China Medical System: Innovative Drug Methylthioninium Chloride Enteric-coated Sustained-release Tablets Approved for Marketing in China
China Medical System Holdings Ltd.
Jun 18, 2024 18:45 HKT/SGT
Olympus Enhances Innovation Capabilities by Expanding R&D to Hyderabad, India
Olympus
Jun 12, 2024 10:00 HKT/SGT
Fujitsu Japan and Juntendo University launch joint research for disaster-resilient, digital medical system
Fujitsu Ltd
Jun 03, 2024 10:02 HKT/SGT
Roche and Hitachi High-Tech extend their long-standing partnership
Hitachi, Ltd.
May 28, 2024 11:53 HKT/SGT
Fujitsu introduces "explainable AI" for use in genomic medicine and cancer treatment planning
Fujitsu Ltd
May 09, 2024 09:41 HKT/SGT
China Medical System: New Drug Application of Desidustat Tablets Accepted in China
China Medical System Holdings Ltd.
Apr 23, 2024 23:06 JST
China Medical System: New Drug Application of Desidustat Tablets Accepted in China
China Medical System Holdings Ltd.
Apr 23, 2024 22:00 HKT/SGT
Autonomix Medical Inc. Covered in Benzinga Article Highlighting Innovative Nerve Treatment Technology
Autonomix Medical Inc.
Apr 16, 2024 17:04 HKT/SGT
Transgene and NEC Present First Clinical Benefits of Neoantigen Cancer Vaccine, TG4050, in Head & Neck Cancer at AACR 2024
NEC Corporation
Apr 10, 2024 12:36 HKT/SGT
NEC white paper proposes comprehensive process workflow for the application of AI-driven personalized cancer vaccines
NEC Corporation
Apr 08, 2024 12:45 HKT/SGT
CMS and Incyte Announce Collaboration and License Agreement for Povorcitinib in China and Southeast Asia
China Medical System Holdings Ltd.
Apr 01, 2024 21:30 JST
CMS and Incyte Announce Collaboration and License Agreement for Povorcitinib in China and Southeast Asia
China Medical System Holdings Ltd.
Apr 01, 2024 20:30 HKT/SGT
China Medical System (867.HK) 2023 Annual Results: Despite of the Temporary Financial Performance Pressure, Fresh Catalysts Emerged from Successive Innovation Breakthroughs
China Medical System Holdings Ltd.
Mar 28, 2024 11:29 JST